AlphaCentric Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
|
|||||
2024
Q3 | $615K | Sell |
|
|||||
2024
Q2 | $1.63M | Buy |
|
|||||
2024
Q1 | $832K | Buy |
|
|||||
2023
Q4 | $814K | Sell |
|
|||||
2023
Q3 | $1.04M | Hold |
|
|||||
2023
Q2 | $1.2M | Hold |
|
|||||
2023
Q1 | $941K | Hold |
|
|||||
2022
Q4 | $796K | Buy |
|
|||||
2021
Q4 | $1.2M | Sell |
|
|||||
2021
Q3 | $1.22M | Buy |
|
|||||
2021
Q2 | $329K | Buy |
|
|||||
2021
Q1 | – | Sell |
|
|||||
2020
Q4 | $126K | Sell |
|
|||||
2020
Q3 | $130K | Buy |
|